Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells

FEBS Journal

Volumn 279, Issue 13, 2012, Pages 2381-2392

  Sun, Zheng ^a   Li, Hong ^a   Shu, Xiao Hong ^a   Shi, Hui ^a   Chen, Xiao Yan ^a   Kong, Qing You ^a   Wu, Mo Li ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Drug metabolism; Glioblastoma multiforme; Resveratrol; Sulfonation activity; Sulfotransferase

Indexed keywords

DRUG METABOLITE; RESVERATROL; RESVERATROL MONOSULFATE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1C2; SULFOTRANSFERASE 4A1; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SENSITIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; SULFONATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARYLSULFOTRANSFERASE; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SPECTROMETRY; NEOPLASM GRADING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; SULFONIC ACIDS; SULFOTRANSFERASES; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

RATTUS;

EID: 84862565826     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08617.x     Document Type: Article

References (34)

1. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, Milzani A & Dalle-Donne I (2010) The potential of resveratrol against human gliomas. Anticancer Drugs 21, 140-150.
2. Kros JM (2011) Grading of gliomas: the road from eminence to evidence. J Neuropathol Exp Neurol 70, 101-109.
3. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temo-zolomide. J Clin Oncol 20, 1375-1382.
4. Polajeva J, Sjosten AM, Lager N, Kastemar M, Waern I, Alafuzoff I, Smits A, Westermark B, Pejler G, Uhrbom L et al. (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS ONE 6, e25222.
5. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-2710.
6. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD & Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
7. Sippel TR, White JT, Nag K, Tsvankin V, Klaassen MK, Kleinschmidt- Demasters BK & Waziri A (2011) Neutrophil degranulation and immunosuppression in patients with glioblastoma: restoration of cellular immune function by targeting arginase I. Clin Cancer Res 17, 6992-7002.
8. Bonfili L, Cecarini V, Amici M, Cuccioloni M, Angeletti M, Keller JN & Eleuteri AM (2008) Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. FEBS J 275, 5512-5526.
9. Saiko P, Szakmary A, Jaeger W & Szekeres T (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658, 68-94.
10. Pervaiz S & Holme AL (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11, 2851-2897.
11. Shu XH, Li H, Sun XX, Wang Q, Sun Z, Wu ML, Chen XY, Li C, Kong QY & Liu J (2011) Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. PLoS ONE 6, e27484.
12. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY & Sun AY (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958, 439-447.
13. Quincozes-Santos A & Gottfried C (2011) Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann N Y Acad Sci 1215, 72-78.
14. Wang Q, Li H, Wang XW, Wu DC, Chen XY & Liu J (2003) Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351, 83-86.
15. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY & Liu J (2008) Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10, 736-744.
16. Wen S, Li H, Wu ML, Fan SH, Wang Q, Shu XH, Kong QY, Chen XY & Liu J (2011) Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation. J Neuro-oncol 104, 167-177.
17. Filippi-Chiela EC, Villodre ES, Zamin LL & Lenz G (2011) Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS ONE 6, e20849.
18. Gagliano N, Moscheni C, Torri C, Magnani I, Bertelli AA & Gioia M (2005) Effect of resveratrol on matrix metalloproteinase- 2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells. Biomed Pharmacother 59, 359-364.
19. Shu XH, Li H, Sun Z, Wu ML, Ma JX, Wang JM, Wang Q, Sun Y, Fu YS, Chen XY et al. (2010) Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Biochem Pharmacol 79, 1516-1525.
20. Asensi M, Medina I, Ortega A, Carretero J, Baño MC, Obrador E & Estrela JM (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33, 387-398.
21. Miksits M, Wlcek K, Svoboda M, Thalhammer T, Ellinger I, Stefanzl G, Falany CN, Szekeres T & Jaeger W (2010) Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism. Cancer Lett 289, 237-245.
22. Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215, 9-15.
23. Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD & Mesecar AD (2010) Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J 429, 273-282.
24. Wang DG, Hang TJ, Wu CY & Liu WY (2005) Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B 829, 97-106.
25. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY & Chen Y (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10, 2190-2202.
26. Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M & McCormick DL (2011) Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol 49, 3319-3327.
27. Castino R, Pucer A, Veneroni R, Morani F, Peracchio C, Lah TT & Isidoro C (2011) Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells. J Agric Food Chem 59, 4264-4272.
28. Li H, Hamou MF, de Tribolet N, Jaufeerally R, Hofmann M, Diserens AC & Van Meir EG (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53, 5345-5349.
29. Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T & Jaeger W (2008) Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261, 172-182.
30. Wang D, Xu T & Liu W (2008) Tissue distribution and excretion of resveratrol in rat after oral administration of Polygonum cuspidatum extract (PCE). Phytomedicine 15, 859-866.
31. Walle T, Hsieh F, Delegge MH, Oatis JE Jr & Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377-1382.
32. Salman ED, Kadlubar SA & Falany CN (2009) Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab Dispos 37, 706-709.
33. Alnouti Y & Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93, 242-255.
34. Mitchell DJ, Butcher NJ & Minchin RF (2011) Phosphorylation/ dephosphorylation of human SULT4A1: role of Erk1 and PP2A. Biochim Biophys Acta 1813, 231-237.